Trade PLUR stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Pluri Inc. (PLUR) is trading at US$1.18, down 5.60% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$18.45M. Over the past 52 weeks, PLUR has traded between US$1.18 and US$4.96. On Syfe you can trade PLUR with $0 commission and add it to your watchlist.
| Previous close | US$1.25 |
|---|---|
| Market cap | US$18.45M |
| 52-week range | US$1.18 – US$4.96 |
| Volume | 9.63K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Pluri Inc.
Pluri, Inc. is a clinical stage company, which engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory, and hematologic conditions. The firm focuses on the research, development, and manufacturing of cell-based products and technologies. Its products include Clinical Pipeline, PLX-Immune, PLX-PAD, and PLX-R18. The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel.
Year: 1991
Pluri Inc. (PLUR) stock is trading at US$1.18, -5.60% from the previous close of US$1.25.
The market cap for Pluri Inc. (PLUR) stock is approximately US$18.45M.
The 52-week high for Pluri Inc. (PLUR) stock is US$4.96.
The 52-week low for Pluri Inc. (PLUR) stock is US$1.18.
Pluri Inc. (PLUR) does not currently pay a dividend.
Stay on top of PLUR
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
